Financhill
Back

Ultragenyx Pharmaceutical, Inc. Stock Price Chart

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
3

RARE
Ultragenyx Pharmaceutical, Inc.

Last Price:
$23.41
Seasonality Move:
2.12%

7 Day Trial

ALL ACCESS PASS

$ 7
  • The current trend is moderately bullish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.

Ultragenyx Pharmaceutical, Inc. Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 29.58 Sell
20-day SMA: 33.19 Sell
50-day SMA: 33.21 Sell
200-day SMA: 33.22 Sell
8-day EMA: 24.98 Sell
20-day EMA: 18.37 Buy
50-day EMA: 9.82 Buy
200-day EMA: 2.87 Buy

Ultragenyx Pharmaceutical, Inc. Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 7.15 Buy
Relative Strength Index (14 RSI): 29.33 Sell
Chaikin Money Flow: 3298451 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (28.87 - 37.75) Sell
Bollinger Bands (100): (28.82 - 34.68) Sell

Ultragenyx Pharmaceutical, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Ultragenyx Pharmaceutical, Inc. Stock

Is Ultragenyx Pharmaceutical, Inc. Stock a Buy?

RARE Technical Analysis vs Fundamental Analysis

Sell
3
Ultragenyx Pharmaceutical, Inc. (RARE) is a Sell

Is Ultragenyx Pharmaceutical, Inc. a Buy or a Sell?

Ultragenyx Pharmaceutical, Inc. Stock Info

Market Cap:
2.2B
Price in USD:
23.00
Share Volume:
3.7M

Ultragenyx Pharmaceutical, Inc. 52-Week Range

52-Week High:
46.50
52-Week Low:
18.41
Sell
3
Ultragenyx Pharmaceutical, Inc. (RARE) is a Sell

Ultragenyx Pharmaceutical, Inc. Share Price Forecast

Is Ultragenyx Pharmaceutical, Inc. Stock a Buy?

Fundamental Analysis of Ultragenyx Pharmaceutical, Inc.

Is Ultragenyx Pharmaceutical, Inc. a good investment?

  • Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.36 per share, and an increase next year of $2.48 per share.

Technical Analysis of Ultragenyx Pharmaceutical, Inc.

Should I short Ultragenyx Pharmaceutical, Inc. stock?

* Ultragenyx Pharmaceutical, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.